Clinical Trial Update: Microcirculatory Alteration and Biomarkers: New Approach for Early Assessment of Septic Multi-organ Dysfunction

View source ↗

Summary

Clinical trial update describing a new approach using microcirculatory alterations and biomarkers for early assessment of septic multi-organ dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome
• Sepsis

Snippet

Sponsor: Prof. Dr. Marc-H. Dahlke, Ph. D. | Conditions: Sepsis, Multiple Organ Failure | Status: UNKNOWN